Human Genome Sciences announces Phase 2 results of mapatumumab combination therapy for NSCLC

Download PDF Copy

Mar 17 2010

NewsGuard 100/100 Score

Human Genome Sciences, Inc. (Nasdaq: HGSI) today announced the results of its randomized Phase 2 trial of mapatumumab (HGS-ETR1) in combination with the chemotherapy agents paclitaxel and carboplatin as first-line therapy in advanced non-small cell lung cancer (NSCLC).

The results showed no difference in disease response or progression-free survival for the combination that included mapatumumab vs. the control group, and showed that mapatumumab was well tolerated in this study. HGS expects to present the results in full at an appropriate scientific meeting later in 2010.

Source Human Genome Sciences

Posted in: Drug Trial News | Medical Procedure News | Medical Condition News

Tags: Anthrax, Antibody, Apoptosis, B Cell, Cancer, Carboplatin, Cell, Chemotherapy, Coronary Heart Disease, Diabetes, Genome, Hepatitis C, Lung Cancer, Lungs, Lupus, Monoclonal Antibody, Multiple Myeloma, Non-Small Cell Lung Cancer, Oncology, Paclitaxel, Small Cell Lung Cancer, T-Cell, Type 2 Diabetes

Comments (0)

Download PDF Copy

Suggested Reading

Neoantigen DNA vaccines improve survival and immunity in triple-negative breast cancer patients

Neoantigen DNA vaccines improve survival and immunity in triple-negative breast cancer patients

Scientists uncover cerebrospinal fluid markers for Alzheimer's detection and treatment

Scientists uncover cerebrospinal fluid markers for Alzheimer's detection and treatment

Study identifies six cancer susceptibility genes

Study identifies six cancer susceptibility genes

Scientists map cancer mutations in EGFR gene, revealing drug resistance paths

Scientists map cancer mutations in EGFR gene, revealing drug resistance paths

Genetic variant identified as potential predictor for severe ulcerative colitis

Genetic variant identified as potential predictor for severe ulcerative colitis

Adolescents' genetic risks tied to psychotic symptoms

Adolescents' genetic risks tied to psychotic symptoms

Genetic risk factors for long-COVID uncovered in a large multi-ethnic study

Genetic risk factors for long-COVID uncovered in a large multi-ethnic study

New insights on the association between genes, gut microbiota, and mental health

New insights on the association between genes, gut microbiota, and mental health

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

Post a new comment

Post

Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...

Rare variant analysis reveals genetic spectrum of monogenic diabetes genes